Cargando…
Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors
It has been indicated that proton pump inhibitor (PPI) use is associated with a loss of the anti-fracture efficacy of alendronate (AD). However, there are few prospective studies that have investigated the efficacy of AD on lumbar bone mineral density (BMD) in osteoporotic patients who are using PPI...
Autores principales: | Asaoka, Daisuke, Nagahara, Akihito, Hojo, Mariko, Matsumoto, Kenshi, Ueyama, Hiroya, Matsumoto, Kohei, Izumi, Kentaro, Takeda, Tsutomu, Komori, Hiroyuki, Akazawa, Yoichi, Shimada, Yuji, Osada, Taro, Watanabe, Sumio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950806/ https://www.ncbi.nlm.nih.gov/pubmed/27446535 http://dx.doi.org/10.3892/br.2016.710 |
Ejemplares similares
-
Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019) -
Association of medications for lifestyle-related diseases with reflux esophagitis
por: Asaoka, Daisuke, et al.
Publicado: (2016) -
Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia
por: Asaoka, Daisuke, et al.
Publicado: (2017) -
A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia
por: Komori, Hiroyuki, et al.
Publicado: (2019) -
The Association between Frailty and Abdominal Symptoms: A Hospital-based Cross-sectional Study
por: Asaoka, Daisuke, et al.
Publicado: (2020)